TIAA CREF Investment Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

TIAA CREF Investment Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-367,693	Closed	-$63.5M	–	3268
2015 Q1	$63.5M	Sell	367,693 -912,624	-71%	-$134M	0.04%	425
2014 Q4	$147M	Sell	1,280,317 -1,313,773	-51%	-$159M	0.1%	229
2014 Q3	$405M	Buy	2,594,090 +597,632	+30%	+$86.6M	0.29%	64
2014 Q2	$246M	Buy	1,996,458 +839,718	+73%	+$92.8M	0.17%	132
2014 Q1	$120M	Sell	1,156,740 -1,414,571	-55%	-$145M	0.09%	262
2013 Q4	$231M	Buy	2,571,311 +188,584	+8%	+$15M	0.17%	131
2013 Q3	$159M	Buy	2,382,727 +1,250,544	+110%	+$86.2M	0.12%	180
2013 Q2	$74.9M	Buy	+1,132,183	New	+$64.7M	0.06%	336

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

TIAA CREF Investment Management's SLXP Position: Q2 2015 in Review

TIAA CREF Investment Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 367,693 shares — an estimated $63.5M sold.

TIAA CREF Investment Management first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $405M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

TIAA CREF Investment Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
TIAA CREF Investment Management sold 367,693 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $63.5M.
TIAA CREF Investment Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
TIAA CREF Investment Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $405M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on TIAA CREF Investment Management's 13F filing for Q2 2015, filed 10 Aug 2015.